1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Metabolic regulation of the cancer-immunity cycle
    Editorial

    Somarribas Patterson, L. F.; Vardhana, S. A.
    Trends in Immunology (2021)

    Fulltext@MSK | Save
  • Promoting spliceosome assembly for therapeutic intent
    Editorial

    Lu, B.; Abdel-Wahab, O.
    Trends in Pharmacological Sciences (2021)

    Fulltext@MSK | Save
  • Idelalisib immune-related toxicity is associated with improved treatment response
    Journal Article

    Wagner-Johnston, N. D.; Sharman, J.; Furman, R. R.; Salles, G.; Brown, J. R.; Robak, T.; Gu, L.; Xing, G.; Chan, R. J.; Rajakumaraswamy, N.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant
    Research Letter

    DiNardo, C. D.; Stein, E. M.; Pigneux, A.; Altman, J. K.; Collins, R.; Erba, H. P.; Watts, J. M.; Uy, G. L.; Winkler, T.; Wang, H.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia
    Research Letter

    Perica, K.; Flynn, J.; Curran, K. J.; Rivere, I.; Wang, X.; Senechal, B.; Halton, E.; Diamonte, C.; Pineda, J.; Bernal, Y.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Dermatologic infections in cancer patients treated with checkpoint inhibitors
    Journal Article

    Do, M. H.; Barrios, D. M.; Phillips, G. S.; Postow, M. A.; Warner, A. B.; Rosenberg, J. E.; Noor, S. J.; Markova, A.; Lacouture, M. E.
    Journal of the American Academy of Dermatology (2021)

    Fulltext@MSK | Save
  • Targeting BCMA in multiple myeloma
    Review

    Tan, C. R.; Shah, U. A.
    Current Hematologic Malignancy Reports (2021)

    Fulltext@MSK | Save
  • Feasibility of combining the phosphatidylinositol 3-kinase inhibitor copanlisib with rituximab-based immunochemotherapy in patients with relapsed indolent B-cell lymphoma
    Journal Article

    Matasar, M. J.; Dreyling, M.; Leppä, S.; Santoro, A.; Pedersen, M.; Buvaylo, V.; Fletcher, M.; Childs, B. H.; Zinzani, P. L.
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementation
    Editorial

    Warlick, E. D.; Ustun, C.; Andreescu, A.; Bonagura, A. F.; Brunner, A.; Chandra, A. B.; Foran, J. M.; Juckett, M. B.; Kindwall-Keller, T. L.; Klimek, V. M.; more...
    Cancer (2021)

    Fulltext@MSK | Save
  • Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)
    Journal Article

    Kantarjian, H. M.; Begna, K. H.; Altman, J. K.; Goldberg, S. L.; Sekeres, M. A.; Strickland, S. A.; Arellano, M. L.; Claxton, D. F.; Baer, M. R.; Gautier, M.; more...
    Cancer (2021)

    Fulltext@MSK | Save